R. Stuart‐Harris
- Oncology top 2%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Molecular Biology
- Co-authors
- Derek RaghavanCarlos CaldasSarah E. PinderPaul D.P. PharoahMichael F. SarosdyIan F. TannockPatrick J. LoehrerLawrence H. Einhorn
- Topics
- Cancer Treatment and Pharmacology (8 papers)Neuroendocrine Tumor Research Advances (5 papers)Lung Cancer Research Studies (5 papers)
- Cited by
- OncologyCancer ResearchSurgery
- Partner nations
- AustraliaUnited KingdomBelgium
In The Last Decade
R. Stuart‐Harris
44 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 1.1k
- Surgery 857
- Pulmonary and Respiratory Medicine 515
- Cancer Research 400
- Molecular Biology 302
Countries citing papers authored by R. Stuart‐Harris
This map shows the geographic impact of R. Stuart‐Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Stuart‐Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Stuart‐Harris more than expected).
Fields of papers citing papers by R. Stuart‐Harris
This network shows the impact of papers produced by R. Stuart‐Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Stuart‐Harris. The network helps show where R. Stuart‐Harris may publish in the future.
Co-authorship network of co-authors of R. Stuart‐Harris
This figure shows the co-authorship network connecting the top 25 collaborators of R. Stuart‐Harris. A scholar is included among the top collaborators of R. Stuart‐Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Stuart‐Harris. R. Stuart‐Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 180 | |
| 2 | 49 | |
| 3 | 22 | |
| 4 | 335 | |
| 5 | 14 | |
| 6 | 19 | |
| 7 | 4 | |
| 8 | 2 | |
| 9 | 6 | |
| 10 | 1 | |
| 11 | A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.breakdown → | 752 |
| 12 | 2 | |
| 13 | 53 | |
| 14 | 4 | |
| 15 | 88 | |
| 16 | Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study. | 28 |
| 17 | 48 | |
| 18 | 11 | |
| 19 | 11 | |
| 20 | 28 |
About R. Stuart‐Harris
R. Stuart‐Harris is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Neuroendocrine Tumor Research Advances (5 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (400 citations) and Surgery (857 citations). R. Stuart‐Harris has collaborated with scholars based in Australia, United Kingdom and Belgium. Frequent co-authors include Derek Raghavan, Carlos Caldas, Sarah E. Pinder, Paul D.P. Pharoah, Michael F. Sarosdy, Ian F. Tannock, Patrick J. Loehrer, Lawrence H. Einhorn, Paul Elson and B A Lowe. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.